Preclinical Research

Medidata in deal on AI biomarker identification for ALS developments

09-Mar-2020 By Vassia Barba

Project ALS has selected Medidata’s biomarker discovery solution for its research projects, aiming to improve understanding of the ALS disease process and develop new therapeutic strategies.

Lunac, Domainex join forces on anticoagulant discovery ‘urgent need’

05-Mar-2020 By Vassia Barba

Domainex is set to support Lunac’s discovery project for anticoagulant therapies with reduced bleeding risk, following the developer’s novel target validation.

Securecell extends reach in Asia, Israel

27-Feb-2020 By Jenni Spinner

The biopharma solutions firm is expanding its footprint with new sales and marketing partners in China, Korea and Israel.

Charles River forms drug discovery pact with CNS-focused biotech

17-Feb-2020 By Nick Taylor

Charles River enters into partnership with Karuna to discover central nervous system therapeutics.

Charles River-backed BioMotiv bears fruit with first biotech

05-Feb-2020 By Ben Hargreaves

BioMotiv and BMS signed an unusual drug development agreement, which has culminated in the launch of Anteros Pharmaceuticals.

Aridis’ cell line ‘halves’ mAb manufacturing time

05-Feb-2020 By Vassia Barba

Aiming to facilitate and accelerate discovery of biologics, Aridis’ Apex platform can also discover antibodies against viruses ‘within one day of a pandemic’.

CROs partner on joint discovery platform to accelerate R&D projects

04-Feb-2020 By Vassia Barba

Leveraging Eurofins’ pharmacology, in-vitro models and ADME capabilities, PharmaResources aims to accelerate drug discovery for its clients in small molecule drug R&D.

BioIVT in deal with upcyte on liver cells for in-vitro research

28-Jan-2020 By Vassia Barba

BioIVT taps into the advantages of hepatic cells for toxicology evaluations and screening studies, securing exclusive distribution agreement with upcyte.

Takeda forms broad drug discovery pact with Charles River

21-Jan-2020 By Nick Taylor

Takeda tasks Charles River with sorting through “plethora” of early stage assets.

Bayer expands women’s health pact with Evotec

16-Jan-2020 By Nick Taylor

Bayer signs five-year, multi-target women’s health collaboration with Evotec, expanding on earlier deal.

Bayer, Schrödinger partner on compound developing software project

13-Jan-2020 By Vassia Barba

Bayer to work with Schrödinger on a molecule design software, which will be integrated into the latter’s LiveDesign, a digital drug design platform.

WuXi Biologics and Almirall partner to develop dermatological treatments

09-Jan-2020 By Vassia Barba

Almirall enters drug discovery agreement with WuXi Biologics, gaining access to the WuXiBody platform to develop antibodies for the treatment of dermatological diseases.

Lonza and Allevi pool resources for 3D bioprinting

07-Jan-2020 By Ben Hargreaves

Lonza signs a collaboration deal with Allevi to offer researchers the tools needed for ‘plug-and-play’ bioprinting for drug research.

ClinOne enters EU with first office in the UK

06-Jan-2020 By Vassia Barba

ClinOne looks to further support its clinical trial partners in the European Union by opening its first office in the region, located in London, UK.

UCL in research partnership with Servier on lupus and sclerosis

24-Dec-2019 By Vassia Barba

Servier is set to support two research projects led by UCL to better understand the immune system’s collapse following infections from immune-inflammatory diseases.